Cargando…
p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization
High morbidity and mortality are associated with acute liver injury (ALI) for which no effective targeted drugs or pharmacotherapies are available. Discovery of potential therapeutic targets as well as inhibitors that can alleviate ALI is imperative. As excessive inflammatory cytokines released by m...
Autores principales: | Peng, Jinjin, Li, Jiacheng, Huang, Jing, Xu, Pan, Huang, Heming, Liu, Yanjun, Yu, Liang, Yang, Yaxi, Zhou, Bing, Jiang, Hualiang, Chen, Kaixian, Dang, Yongjun, Zhang, Yuanyuan, Luo, Cheng, Li, Guangming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857059/ https://www.ncbi.nlm.nih.gov/pubmed/31754401 http://dx.doi.org/10.7150/thno.30707 |
Ejemplares similares
-
Selective inhibition of CBP/p300 HAT by A-485 results in suppression of lipogenesis and hepatic gluconeogenesis
por: Zhou, Feiye, et al.
Publicado: (2020) -
Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
por: Chen, Qingjuan, et al.
Publicado: (2022) -
Protein Lysine Acetylation
by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2015) -
Curcumin, COX-2, and Protein p300/CBP
por: Jung, Ki Tae, et al.
Publicado: (2014) -
Dimeric structure of p300/CBP associated factor
por: Shi, Shasha, et al.
Publicado: (2014)